Michal Rolinski
Overview
Explore the profile of Michal Rolinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swainson A, Woodward K, Boca M, Rolinski M, Collard P, Cerminara N, et al.
Neuropsychologia
. 2023 Sep;
189:108681.
PMID: 37709193
There is currently mixed evidence on the effect of Parkinson's disease on motor adaptation. Some studies report that patients display adaptation comparable to age-matched controls, while others report a complete...
2.
Roguski A, Rolinski M, Jones M, Whone A
Clin Park Relat Disord
. 2023 Jan;
8:100176.
PMID: 36594073
Introduction: The earliest stages of alpha-synucleinopathies are accompanied by non-specific prodromal symptoms such as diminished sense of smell, constipation and depression, as well as more specific prodromal conditions including REM...
3.
Miglis M, Adler C, Antelmi E, Arnaldi D, Baldelli L, Boeve B, et al.
Lancet Neurol
. 2021 Jul;
20(8):671-684.
PMID: 34302789
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly regarded as being in the early stages of a progressive neurodegenerative disease involving α-synuclein pathology, such as Parkinson's disease, dementia...
4.
Baig F, Boca M, Mooney L, Cheminais L, Selikhova M, Rolinski M, et al.
Parkinsonism Relat Disord
. 2021 Jul;
89:34-37.
PMID: 34218045
Background: Procedural aspects and complications of gastrojejunostomy insertion are important considerations in the use of levodopa-carbidopa intestinal gel therapy (LCIG) and may limit uptake. We describe our experience of using...
5.
Zokaei N, Gillebert C, Chauvin J, Gresch D, Board A, Rolinski M, et al.
Eur J Neurosci
. 2021 Jan;
53(8):2713-2725.
PMID: 33450082
Temporal orienting of attention can affect multiple stages of processing to guide adaptive behaviour. We tested whether temporal expectation in different task contexts is compromised in individuals with Parkinson's disease...
6.
Arnaldi D, Chincarini A, Hu M, Sonka K, Boeve B, Miyamoto T, et al.
Brain
. 2020 Dec;
144(1):278-287.
PMID: 33348363
This is an international multicentre study aimed at evaluating the combined value of dopaminergic neuroimaging and clinical features in predicting future phenoconversion of idiopathic REM sleep behaviour (iRBD) subjects to...
7.
Morgan C, Craddock I, Tonkin E, Kinnunen K, McNaney R, Whitehouse S, et al.
BMJ Open
. 2020 Dec;
10(11):e041303.
PMID: 33257491
Introduction: The impact of disease-modifying agents on disease progression in Parkinson's disease is largely assessed in clinical trials using clinical rating scales. These scales have drawbacks in terms of their...
8.
Griffanti L, Klein J, Szewczyk-Krolikowski K, Menke R, Rolinski M, Barber T, et al.
BMJ Open
. 2020 Aug;
10(8):e034110.
PMID: 32792423
Purpose: The Oxford Parkinson's Disease Centre (OPDC) Discovery Cohort MRI substudy (OPDC-MRI) collects high-quality multimodal brain MRI together with deep longitudinal clinical phenotyping in patients with Parkinson's, at-risk individuals and...
9.
Roguski A, Rayment D, Whone A, Jones M, Rolinski M
Front Neurol
. 2020 Aug;
11:610.
PMID: 32733361
REM Sleep Behavior Disorder (RBD) is a chronic sleep condition characterized by dream enactment and loss of REM atonia. Individuals often present to clinic with complaints of injury to themselves...
10.
Morgan C, Rolinski M, McNaney R, Jones B, Rochester L, Maetzler W, et al.
J Parkinsons Dis
. 2020 Apr;
10(2):429-454.
PMID: 32250314
Background: The emergence of new technologies measuring outcomes in Parkinson's disease (PD) to complement the existing clinical rating scales has introduced the possibility of measurement occurring in patients' own homes...